DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Tolmetin (Tolmetin Sodium) - Summary

 

-- advertisement --

BOXED WARNING

Cardiovascular Risk

  • NSAIDs1 may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk (see WARNINGS).
  • Tolmetin sodium capsules are contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery (see CONTRAINDICATIONS and WARNINGS).

Gastrointestinal Risk

  • NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk for serious gastrointestinal events (see WARNINGS).
1 Throughout this package insert, the term NSAID refers to a non-aspirin non-steroidal anti-inflammatory drug.
 

TOLMETIN SUMMARY

TOLMETIN SODIUM CAPSULES USP

Tolmetin sodium is a nonselective non-steroidal anti-inflammatory agent. Each capsule, for oral administration, contains 492 mg of tolmetin sodium (as the dihydrate), equivalent to 400 mg of tolmetin.

Carefully consider the potential benefits and risks of tolmetin sodium capsules and other treatment options before deciding to use tolmetin sodium capsules. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS).

Tolmetin sodium capsules are indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis. Tolmetin sodium capsules are indicated in the treatment of acute flares and the long-term management of the chronic disease.

Tolmetin sodium capsules are also indicated for treatment of juvenile rheumatoid arthritis. The safety and effectiveness of tolmetin sodium capsules have not been established in pediatric patients under 2 years of age (see PRECAUTIONS, Pediatric Use and DOSAGE AND ADMINISTRATION).

TOLMETIN NEWS HIGHLIGHTS

Media Articles Related to Tolmetin

Study Shows EUFLEXXA(R) Patients Report Significant Improvements In Osteoarthritis Of The Knee Pain Over A Six Month Period
Source: Arthritis / Rheumatology News From Medical News Today [2008.10.08]

Occupational Therapy Plus Exercise Benefits Osteoarthritis
Source: MedicineNet Arthritis Specialty [2008.10.01]

Supplements No Better Than Placebo In Slowing Cartilage Loss In Knees Of Osteoarthritis Patients
Source: Arthritis / Rheumatology News From Medical News Today [2008.09.30]

X-Ray Evidence Shows Popular Supplements Fail to Slow Knee Osteoarthritis
Source: MedPage Today Primary Care [2008.09.30]

Occupational Therapy Plus Exercise Benefits Osteoarthritis (HealthDay)
Source: Y! Health Arthritis News [2008.09.30]

more>>

Published Studies Related to Tolmetin

Morphological features of rat gastric mucosa after acute and chronic treatment with amtolmetin guacyl: comparison with non-selective and COX-2-selective NSAIDs. [2003]

[An evaluation of the therapeutic activity and tolerance of ST-679 in patients with osteoarthritis at different sites. A controlled double-blind study vs tolmetin] [1993.01]

Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. [1988.08]

A crossover study of naproxen, diclofenac and tolmetin in seronegative juvenile chronic arthritis. [1988.04]

more>>

Page last updated: 2008-10-08

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008